What Palisade Bio Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 10 |
| Sells | 0 | 4 |
| Total trades | 9 | 34 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 6,743,934 | 10,825,108 |
| Disposed | 2,531,484 | 2,736,047 |
| Net activity | +4,212,450 | +8,089,061 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Capers Julien E. | See Remarks | Oct 19 | Grant / award · A | +787,300 | — | — | 787,300 |
| Finley John David | CEO CFO | Oct 06 | Withheld — tax / exercise cost · F | −1,411,982 | $1.49 | −$2.1M | 1,944,690 |
| Finley John David | CEO CFO | Oct 06 | Exercise / conversion · M | +3,227,384 | — | — | 3,356,672 |
| Jones Mitchell Lawrence | See Remarks | Oct 06 | Withheld — tax / exercise cost · F | −1,031,102 | $1.49 | −$1.54M | 1,683,757 |
| Jones Mitchell Lawrence | See Remarks | Oct 06 | Exercise / conversion · M | +2,620,850 | — | — | 2,714,859 |
| Williams Donald Allen | Director | Oct 02 | Open-market buy · P | +10,000 | $1.46 | +$14.6K | 1,590,294 |
| Williams Donald Allen | Director | Oct 01 | Open-market buy · P | +10,000 | $1.42 | +$14.2K | 1,580,294 |
| Finley John David | CEO, CFO | Aug 19 | Gift · G | +88,400 | — | — | 88,451 |
| Finley John David | CEO, CFO | Aug 19 | Gift · G | −88,400 | — | — | 129,288 |
| Baltera Robert Jr. | Director | Jul 09 | Open-market buy · P | +25,000 | $1.96 | +$48.9K | 461,904 |
| Baltera Robert Jr. | Director | Jul 08 | Open-market buy · P | +20,000 | $1.99 | +$39.8K | 436,904 |
| Jones Mitchell Lawrence | Chief Medical Officer | Jul 07 | Open-market sale · S | −51,880 | $2.05 | −$107K | 94,009 |
| Baltera Robert Jr. | Director | Jul 07 | Open-market buy · P | +30,000 | $2.03 | +$61K | 416,904 |
| Finley John David | CEO, CFO | Jul 07 | Exercise / conversion · M | +133 | $0.70 | +$93.1 | 217,688 |
| Finley John David | CEO, CFO | Jul 07 | Open-market sale · S | −146,798 | $2.07 | −$303K | 217,555 |
| Jones Mitchell Lawrence | Chief Medical Officer | Jul 06 | Exercise / conversion · M | +131,167 | — | — | 145,889 |
| Baltera Robert Jr. | Director | Jul 06 | Open-market buy · P | +20,000 | $2.05 | +$41K | 386,904 |
| Finley John David | CEO, CFO | Jul 06 | Exercise / conversion · M | +335,167 | — | — | 364,353 |
| Baltera Robert Jr. | Director | Jul 02 | Open-market buy · P | +10,000 | $1.98 | +$19.8K | 366,904 |
| Baltera Robert Jr. | Director | Jul 01 | Open-market buy · P | +20,000 | $1.98 | +$39.6K | 356,904 |
Loading...
